Clik here to view.
GeneNews’ JV IDL launches Beckman Coulter’s phi test across U.S.
GeneNews’ (TSX:GEN) recently formed joint venture, Innovative Diagnostic Laboratory, has added Beckman Coulter Diagnostics’ Prostate Health Index (phi) to its menu of advanced cancer assays and has...
View ArticleClik here to view.
GeneNews IDL JV posts big jumps in tests processed
GeneNews’ (TSX:GEN) recently formed U.S. joint venture, Innovative Diagnostic Laboratory (IDL), has reported a 346% sequential jump in tests processed during the first quarter, compared with the 2013...
View ArticleClik here to view.
GeneNews’ IDL off to flying start
GeneNews’ (TSX:GEN) recently formed U.S. joint venture, Innovative Diagnostic Laboratory (IDL), took a huge step forward in the first quarter in its goal of becoming a leader in molecular diagnostics...
View ArticleClik here to view.
PHI test included in updated NCCN Guidelines
Beckman Coulter’s Prostate Health Index (PHI), which is offered in the U.S. by GeneNews’ (TSX:GEN) Innovation Diagnostic Lab (IDL) joint venture, has been recommended by the National Comprehensive...
View ArticleClik here to view.
GeneNews’ IDL jv highlighted on CEO Clips
James Howard-Tripp, executive chairman of GeneNews (TSX:GEN), has been featured on Business Television’s CEO Clips discussing the company’s new U.S. joint venture, Innovative Diagnostic Laboratory, or...
View ArticleClik here to view.
GeneNews Q2 JV lab test volumes more than triple sequentially
GeneNews’ (TSX:GEN) U.S. joint venture, Innovative Diagnostic Laboratory (IDL), processed 46,051 tests in the second quarter, up more than threefold sequentially from the 14,680 tests processed in the...
View ArticleClik here to view.
GeneNews’ IDL to provide prostate testing to MD Anderson
GeneNews’ (TSX:GEN) Innovative Diagnostic Laboratory (IDL) joint venture has agreed to provide its prostate health index (PHI) testing services to MD Anderson Cancer Center. “There is significant...
View Article
